Typically used in Type 2 Diabetes they decrease glucose absorption and increase urinary glucose excretion. FDA Warns of Ketoacidosis Risk with Newer Diabetes Drugs.
Originally posted on DOT FMCSA-FAA-USCG-Rules-Regulations| Randolph Rosarion M.D.:
May 10, 2013, the Federal Motor Carrier Safety Administration (FMCSA) published the Medical Examiner’s Certification Integration notice of proposed rulemaking (NPRM) (78 FR 27343). To also view the docket folder for all related documents click Docket ID: FMCSA-2012-0178. On April 23, 2015 FMCSA published the Final Rule which has an effective date of June 22, 2015. Excerpts from FMCSA’s Final Rule: SUMMARY FMCSA amends the Federal Motor Carrier Safety Regulations (FMCSRs) to require…
New diabetes standard for commercial drivers in the works: Land Line Magazine.